Previous 10 | Next 10 |
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. F...
LeMaitre Vascular ( NASDAQ: LMAT ) stock fell ~16% on Friday after Q3 results missed estimates and the company lowered its Q4 and FY22 outlook. Q3 EPS declined -16.7% Y/Y to $0.25, while net sales grew ~1.7% Y/Y to $39.03M. Both metrics, however, missed analysts esti...
LeMaitre Vascular, Inc. (LMAT) Q3 2022 Results Conference Call October 27, 2022 05:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer David Roberts - President Conference Call Participants Michael Sarcone - Jefferies Brooks O ...
LeMaitre Vascular press release ( NASDAQ: LMAT ): Q3 Non-GAAP EPS of $1.05 beats by $0.77 . Revenue of $39.03M (+1.6% Y/Y) misses by $1.03M . For further details see: LeMaitre Vascular Non-GAAP EPS of $1.05 beats by $0.77, revenue of $39.03M misses by $1....
BURLINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2022 results, announced a $0.125/share quarterly dividend and provided guidance. Q3 2022 Financial Results Sales of $39....
BURLINGTON, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2022 financial results on Thursday, October 27, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET the same...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While several stocks under $50 to buy exist in the equities sector, which ones are worthwhile to hold onto forever? Identifying these picks in an unenviable task. However, given the worrying backdrop of the global economy, ...
Summary We reiterate the buy call on LeMaitre Vascular. The company's capital management strategies continue to yield double-digit ROI from its invested capital. With $75mm on the balance sheet, management notes the strategy is focused on acquisitions looking ahead. Q2 num...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...
BURLINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in a fireside chat at the Morgan Stanley 20 th Annual Global Healthcare Conference on Wednesday, September 14, 2022, at 4:40 PM ET a...
News, Short Squeeze, Breakout and More Instantly...
LeMaitre Vascular Inc. Company Name:
LMAT Stock Symbol:
NASDAQ Market:
LeMaitre Vascular Inc. Website:
2024-06-23 00:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-01 09:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BURLINGTON, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City...